Gennex Laboratories Ltd
BSE:531739

Watchlist Manager
Gennex Laboratories Ltd Logo
Gennex Laboratories Ltd
BSE:531739
Watchlist
Price: 12.26 INR 1.24% Market Closed
Market Cap: ₹3B

Net Margin

12.7%
Current
Improving
by 0.2%
vs 3-y average of 12.5%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
12.7%
=
Net Income
₹189.7m
/
Revenue
₹1.5B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
12.7%
=
Net Income
₹189.7m
/
Revenue
₹1.5B

Peer Comparison

Country Company Market Cap Net
Margin
IN
Gennex Laboratories Ltd
BSE:531739
3B INR
Loading...
US
Eli Lilly and Co
NYSE:LLY
954.9B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
546.2B USD
Loading...
CH
Roche Holding AG
SIX:ROG
269.4B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
208.2B GBP
Loading...
CH
Novartis AG
SIX:NOVN
218.2B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
265.4B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
147.6B USD
Loading...
FR
Sanofi SA
PAR:SAN
94.2B EUR
Loading...

Market Distribution

Higher than 72% of companies in India
Percentile
72nd
Based on 5 531 companies
72nd percentile
12.7%
Low
-305 007.7% — 2.1%
Typical Range
2.1% — 11.6%
High
11.6% — 1 221 633.3%
Distribution Statistics
India
Min -305 007.7%
30th Percentile 2.1%
Median 5.8%
70th Percentile 11.6%
Max 1 221 633.3%

Gennex Laboratories Ltd
Glance View

Market Cap
3B INR
Industry
Pharmaceuticals

Gennex Laboratories Ltd. engages in the manufacture of bulk drugs and intermediates products. The company is headquartered in Hyderabad, Telangana. The firm is engaged in the business of manufacturing of bulk drugs, intermediaries and biotech products. The firm has a robust product portfolio spread over major product segments encompassing expectorants, muscle relaxants, analgesic and anti-fungal. The firm operates through Pharmaceutical Products (Bulk Drugs) segment. The firm's products include active pharmaceutical ingredients, such as Guaifenesin USP/BP/EP/IP, which is an expectorant, (mucolyte); Methocarbamol USP, which is a relaxant (skeletal muscle relaxant); Phenazopyridine Hcl USP, which is an urinary tract analgesic; Fluconazole EP/USP, which is an anti-fungal product; Mephenesin IP/BP, which is a muscle relaxant; Chlorphenesin IP/BP, which is anti-fungal, and Melitracen Hcl, which is an antidepressant. The firm has manufacturing facilities in India which caters to both domestic and international markets.

GENNEX Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
12.7%
=
Net Income
₹189.7m
/
Revenue
₹1.5B
What is Gennex Laboratories Ltd's current Net Margin?

The current Net Margin for Gennex Laboratories Ltd is 12.7%, which is above its 3-year median of 12.5%.

How has Net Margin changed over time?

Over the last 3 years, Gennex Laboratories Ltd’s Net Margin has increased from 5.3% to 12.7%. During this period, it reached a low of 5.3% on Aug 30, 2022 and a high of 15.2% on Mar 31, 2024.

Back to Top